Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease

Part of paid clinical trials in Memphis, Tennessee.

Sponsor
Nitin Goyal
Study ID
NCT06790147
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to establish a prospective multicenter registry of patients undergoing intracranial stenting for ischemic strokes caused by medically refractory ICAD. The study aims to evaluate current practice patterns, periprocedural outcomes, and delayed outcomes. Researchers will collect demographic and procedural data from patients who undergo intracranial stenting after having an ischemic stroke caused by medically refractory ICAD.

Key Dates

Start date
Aug 31, 2025
Status verified
May 2025
Primary completion
Aug 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
150 participants (estimated)

Primary Outcome Measure

Recurrent ischemic stroke within treated territory, ICH, or death [ Time Frame: 72 hours post procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Semmes Murphey ClinicMemphisTennessee38120
Courtney Berryman
[email protected]
901-260-6111
Olivia House
[email protected]
901-522-7785
Nitin Goyal, MD (PRINCIPAL_INVESTIGATOR)
Violiza Inoa, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Memphis, TN

By condition
Stroke
By specialty
NeurologyBrain disorders
By research site
Semmes Murphey Clinic· Memphis, TN

Related Studies